Dolby Laboratories, Inc. (DLB) Financial Statements
Industry: Patent Owners & Lessors
In fiscal 2025, Dolby Laboratories reported revenue of $1.35B, up 5.9% from $1.27B the year before. Net income was $255.0M (a 18.9% net margin), or $2.62 per diluted share. Gross margin was 88.1% and operating margin was 19.6%. Operating activities generated $472.2M of cash, leaving $435.9M of free cash flow. At fiscal year end, Dolby Laboratories held $3.23B in total assets against $595.8M in total liabilities, including $701.9M of cash and equivalents.
Open the full interactive Dolby Laboratories financials → Quarterly statements, key ratios, valuation history and price charts.
Dolby Laboratories Key Stats
| Share Price | $58.36 |
|---|---|
| Market Cap | $5.52B |
| P/E Ratio | 22.3 |
| Revenue YoY Growth | +5.9% |
| 52-Week Range | $48.23 – $68.26 |
| Shares Outstanding | 94.2 million (basic, 2026 Q3) |
Dolby Laboratories Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.16B | $1.28B | $1.25B | $1.30B | $1.27B | $1.35B |
| Gross Profit | $1.02B | $1.15B | $1.11B | $1.15B | $1.13B | $1.19B |
| Operating Income | $218.7M | $344.4M | $206.6M | $215.8M | $258.3M | $265.0M |
| Pre-Tax Income | $239.7M | $354.5M | $215.3M | $250.1M | $312.5M | $303.5M |
| Income Tax | $8.1M | $36.7M | $31.4M | $48.4M | $48.2M | $47.0M |
| Net Income | $231.4M | $310.2M | $184.1M | $200.7M | $261.8M | $255.0M |
| Diluted EPS | $2.25 | $2.97 | $1.81 | $2.05 | $2.69 | $2.62 |
Dolby Laboratories Quarterly Results
| 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | |
|---|---|---|---|---|
| Revenue | $307.0M | $346.7M | $395.6M | $305.0M |
| Net Income | $49.3M | $53.3M | $94.9M | $28.6M |
| Diluted EPS | $0.51 | $0.55 | $0.99 | $0.30 |
Dolby Laboratories Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.07B | $1.23B | $620.1M | $745.4M | $482.0M | $701.9M |
| Current Assets | $1.55B | $1.76B | $1.31B | $1.49B | $1.19B | $1.39B |
| Total Assets | $2.92B | $3.11B | $2.69B | $2.98B | $3.11B | $3.23B |
| Current Liabilities | $267.1M | $315.7M | $277.5M | $422.2M | $417.8M | $437.8M |
| Total Liabilities | $478.9M | $501.5M | $438.5M | $607.6M | $623.0M | $595.8M |
| Shareholders' Equity | $2.43B | $2.60B | $2.25B | $2.36B | $2.48B | $2.62B |
Dolby Laboratories Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $343.8M | $447.8M | $318.6M | $367.1M | $327.3M | $472.2M |
| Cash From Investing | $134.4M | -$44.9M | -$295.9M | $54.2M | -$286.3M | -$10.6M |
| Cash From Financing | -$207.8M | -$252.5M | -$610.6M | -$236.8M | -$287.8M | -$247.2M |
| Free Cash Flow | $277.5M | $393.3M | $270.6M | $336.7M | $297.2M | $435.9M |
Figures from Dolby Laboratories' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Dolby Laboratories financials page for every line item.
Dolby Laboratories Company Profile
| Ticker | DLB |
|---|---|
| Exchange | NYSE |
| Industry | Patent Owners & Lessors |
| Headquarters | San Francisco, California |
| Incorporated in | Delaware |
| Fiscal Year End | September 27 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001308547 |
Frequently Asked Questions
What was Dolby Laboratories' revenue in fiscal 2025?
Dolby Laboratories (DLB) reported revenue of $1.35B for fiscal 2025.
What is Dolby Laboratories' annual revenue history?
Dolby Laboratories' annual revenue by fiscal year: 2020: $1.16B; 2021: $1.28B; 2022: $1.25B; 2023: $1.30B; 2024: $1.27B; 2025: $1.35B.
What was Dolby Laboratories' net income in fiscal 2025?
Dolby Laboratories reported net income of $255.0M for fiscal 2025.
What was Dolby Laboratories' earnings per share (EPS) in fiscal 2025?
Dolby Laboratories' diluted EPS was $2.62 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Dolby Laboratories generate in fiscal 2025?
Dolby Laboratories generated $435.9M of free cash flow in fiscal 2025.
What was Dolby Laboratories' revenue last quarter?
In its most recent reported quarter (2026 Q3), Dolby Laboratories reported revenue of $305.0M.
How many shares of Dolby Laboratories are outstanding?
Dolby Laboratories reported a weighted average of 94.2 million basic shares outstanding in 2026 Q3.
What is Dolby Laboratories' market cap?
Based on its latest closing price, Dolby Laboratories (DLB) has a market capitalization of about $5.52B.
When does Dolby Laboratories' fiscal year end?
Dolby Laboratories' fiscal year end, as registered with the SEC, is September 27.
Where is Dolby Laboratories headquartered?
Dolby Laboratories lists its business address in San Francisco, California in its SEC filings.